| Symbol | NTHI |
|---|---|
| Name | NEONC TECHNOLOGIES HOLDINGS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 23975 PARK SORRENTO,SUITE 205, CALABASAS, California, 91302, United States |
| Telephone | +1 818-570-6844 |
| Fax | — |
| — | |
| Website | https://neonc.com/ |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001979414 |
| Description | Our company (NAS-ONC, Inc.) was formed in 2008, devoted to developing new drugs with new delivery modes. As a clinical-stage biopharmaceutical company, we have focused on establishing treatments for intracranial malignancies, i.e., aggressive cancers located in the brain. These cancer types include primary brain cancers, such as glioblastoma, and secondary brain cancers, that have arrived through metastatic spread from other cancers throughout the body, such as melanoma or breast and lung cancer. Additional info from NASDAQ: |
New Form S-3 - NEONC TECHNOLOGIES HOLDINGS, INC. <b>Filed:</b> 2026-06-15 <b>AccNo:</b> 0001829126-26-006487 <b>Size:</b> 486 KB
Read more(99% Neutral) NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) Announces Business Combination
Read moreNew Form PRE 14A - NEONC TECHNOLOGIES HOLDINGS, INC. <b>Filed:</b> 2026-06-11 <b>AccNo:</b> 0001829126-26-006384 <b>Size:</b> 427 KB
Read moreNeOnc Technologies Gains Growing Institutional Support Ahead of Key Brain Cancer Clinical Milestones
Read more(90% Positive) NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) Announces Enrollment Update for study Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment
Read moreNew Form SCHEDULE 13G - NEONC TECHNOLOGIES HOLDINGS, INC. <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0000905148-26-002410 <b>Size:</b> 20 KB
Read moreHeshmatpour Amir F 🟢 acquired 10.0K shares of NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) at $4.16 Transaction Date: May 01, 2026 | Filing ID: 051440
Read more